The global renal denervation systems market size reached US$ 218.2 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,723.6 Million by 2027, exhibiting a growth rate (CAGR) of 40.67% during 2022-2027. More Info:- https://www.imarcgroup.com/renal-denervation-systems-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Renal Denervation Systems
Market Research and Forecast
Report 2022-2027
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Renal Denervation Systems Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled "Renal Denervation Systems Market: Global
Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global renal
denervation systems market size reached US$ 218.2 Million in 2021.
Renal denervation (RDN) refers to a minimally invasive, catheter-based procedure that is performed
to treat resistant hypertension. It involves a radiofrequency ablation, which burns the nerves within
the renal arteries. This, in turn, suppresses the nerve activity and modulates the output of the
sympathetic nerves, thereby assisting in decreasing the blood pressure.
In addition to this, it lowers renin secretion, improves blood flow, and stimulates natriuresis.
Consequently, RDN systems is being widely adopted to treat hypertension coexisting with metabolic
abnormalities, sleep apnea, heart failure, chronic kidney disease, and arrhythmias.
Request for a PDF sample of this report: https://www.imarcgroup.com/renal-denervation-
systems-market/requestsample

4. Report Description
Report Description and Highlights
Global Renal Denervation Systems Market Trends:
The global RDN systems market is majorly being driven by the growing instances of lifestyle-related
disorders, such as therapy-resistant hypertension, due to sedentary lifestyle, evolving dietary habits,
and the increasing cigarette smoking population. This is further supported by the rising geriatric
population, which is more susceptible to developing such ailments. Moreover, the growingawareness
regarding the clinical advantages associated with RDN systems, including quick recovery, cost-
effectiveness, and minimal complications are also facilitating the product demand across the globe.
Other than this, continuous investments in research and development (R&D) activities to introduce
alternative technologies for RDN, such as micro-infusion, is acting as another growth-inducing factor.
Additionally, increasing clinical trials to validate clinical efficiency of RDN over conventional surgeries are
creating a positive outlook for the market further.
Looking forward, the market is expected to grow at a CAGR of 40.67% during 2022-2027.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/renal-denervation-systems-
market

5. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Product Type:
•Catheters
o Single Electrode Catheter
o Multi Electrode Catheter
•RF Generator
•Nerve Modifying Agents
Breakup by Product:
•Symplicity
•Vessix (V2)
•EnligHTN
•Paradise
•Iberis
•Others
Breakup by Technology:
•Ultrasound Ablation

6. Report Description
Report Description and Highlights
•Radiofrequency Ablation
•Microinfusion
Breakup by Application:
•Hypertension
•Cardiac Disorders
•Diabetes
•Renal Failure
•Others
Breakup by End User:
•Diagnostic Centers and Hospitals
•Ambulatory Care Centers
•Others
Breakup by Region:
•North America
•Asia Pacific
•Europe
•Latin America
•Middle East and Africa

7. Report Description
Report Description and Highlights
Competitive Landscape with Key Players:
•Boston Scientific Group
•Kona Medical Inc
•Medtronic Plc
•Mercator MedSystems
•ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
•Renal Dynamics
•St. Jude Medical Inc. (Abbott)
•Terumo Corporation

8. Report Description
Key Questions Answered in the Report
1. How has the global renal denervation systems market performed so far and how will it perform
in the coming years?
2. What are the key regional markets?
3. What has been the impact of COVID-19 on the global renal denervation systems market?
4. What is the breakup of the market based on the product type?
5. What is the breakup of the market based on the product?
6. What is the breakup of the market based on the technology?
7. What is the breakup of the market based on the application?
8. What is the breakup of the market based on the end user?
9. What are the various stages in the value chain of the industry?
10. What are the key driving factors and challenges in the industry?
11. What is the structure of the global renal denervation systems market and who are the key
players?
12. What is the degree of competition in the industry?

9. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Renal Denervation Systems Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

10. Report Description Table of Contents
6 Market Breakup by Product Type
6.1 Catheters
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Single Electrode Catheter
6.1.2.2 Multi Electrode Catheter
6.1.3 Market Forecast
6.2 RF Generator
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Nerve Modifying Agents
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Product
7.1 Symplicity
7.1.1 Market Trends
7.1.2 Market Forecast
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/renal-denervation-systems-market/toc

11. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

14. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us